Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Circulation|January 24, 2012
C/EBP homologous protein-10 (CHOP-10) limits postnatal neovascularization through control of endothelial nitric oxide synthase gene expressionCéline Loinard, Yasmine Zouggari, Patricia Rueda, et al.
Journal of Thoracic Disease|February 13, 2019
Predictive factors of postoperative survival among patients with pulmonary neuroendocrine tumorYoshinobu Ichiki, Hiroki Matsumiya, Masataka Mori, et al.
Journal of Thoracic Disease|June 11, 2019
Prognostic factors of advanced or postoperative recurrent non-small cell lung cancer targeted with immune check point inhibitorsYoshinobu Ichiki, Akihiro Taira, Yasuhiro Chikaishi, et al.
Surgical Case Reports|May 4, 2019
Fenestration without rib resection for postoperative bronchopleural fistulaMasatoshi Kanayama, Yoshinobu Ichiki, Katsuma Yoshimatsu, et al.
Gland Surgery|September 16, 2021
Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experienceYusuke Nabe, Teppei Hashimoto, Kanji Tanaka, et al.
Journal of Thoracic Disease|September 4, 2018
Outcomes of patients undergoing surgery for thymic carcinoma: a single-center experienceYusuke Nabe, Yoshinobu Ichiki, Yukiko Fukuichi, et al.
Cancers|July 29, 2025
Establishing a Highly Accurate Circulating Tumor Cell Image Recognition System for Human Lung Cancer by Pre-Training on Lung Cancer Cell LinesHiroki Matsumiya, Kenji Terabayashi, Yusuke Kishi, et al.
In Vivo (Athens, Greece)|June 30, 2026
Impact of CD73/CD155 Expression on Survival in Resected Epithelial Pleural Mesothelioma: A Retrospective Single-center StudyYusuke Nabe, Yasuhiro Fujita, Teppei Hashimoto, et al.
Cancer Treatment and Research Communications|October 2, 2025
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study)Hidenobu Ishii, Koichi Azuma, Fumiaki Kiyomi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignanciesAmita Patnaik, S Gail Eckhardt, Elzbieta Izbicka, et al.
Pageof 10